CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 81 filers reported holding CUE BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,507 | -28.4% | 797 | 0.0% | 0.00% | – |
| Q4 2023 | $2,105 | +14.8% | 797 | 0.0% | 0.00% | – |
| Q3 2023 | $1,834 | -37.0% | 797 | 0.0% | 0.00% | – |
| Q2 2023 | $2,910 | +2.2% | 797 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $2,846 | +25.3% | 797 | 0.0% | 0.00% | – |
| Q4 2022 | $2,271 | +13.6% | 797 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 797 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $2,000 | -50.0% | 797 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $4,000 | -55.6% | 797 | 0.0% | 0.00% | -66.7% |
| Q4 2021 | $9,000 | – | 797 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,437,445 | $21,634,000 | 10.97% |
| Prosight Management, LP | 709,936 | $10,685,000 | 5.08% |
| Voss Capital, LP | 226,573 | $3,410,000 | 1.94% |
| Robertson Stephens Wealth Management, LLC | 484,000 | $7,284,000 | 1.79% |
| Slate Path Capital LP | 1,483,619 | $22,328,000 | 1.27% |
| Nantahala Capital Management | 2,342,216 | $35,250,000 | 1.08% |
| SANDERS MORRIS HARRIS LLC | 142,430 | $2,312,000 | 0.63% |
| Rock Creek Group, LP | 80,000 | $1,204,000 | 0.62% |
| PRECEPT MANAGEMENT LLC | 150,000 | $2,258,000 | 0.55% |
| PA Capital LLC | 46,850 | $705,000 | 0.50% |